# A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure

> **NCT00739193** · PHASE2 · WITHDRAWN · sponsor: **Prism Pharmaceuticals**

## Conditions studied

- Blood Pressure

## Interventions

- **DRUG:** amiodarone

## Key facts

- **NCT ID:** NCT00739193
- **Lead sponsor:** Prism Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739193, "A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00739193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*